FintastIQ
Book a Consultation

Marketing / gtm alignment

Reading Go-to-Market Alignment Through a Value-Creation Lens

· 2025-05-30

Ninety days into your hold period, your operating team has reviewed the P&L, walked the pipeline, and sat in on several sales calls. The numbers look fine. Win rates are reasonable. The sales team seems capable. But something is off, and nobody can name it cleanly.

Usually, that feeling is go-to-market (GTM) misalignment. Not a broken product, not a broken sales team. A mismatch between who you're selling to, what you're promising them, and whether your product can deliver on that promise at the price you're charging.

The Silent Cost

GTM misalignment has a specific financial signature in portfolio companies, though it rarely gets labeled correctly on the P&L.

The first symptom is high early-stage churn. Customers who leave in months 6-18 are almost always a GTM problem, not a product problem. They were sold to with the wrong value proposition, landed in the wrong use case, or set up with expectations your customer success (CS) team can't meet. In a $22M annual recurring revenue (ARR) business, 15% early churn on new cohorts costs roughly $3.3M in ARR annually. At an 8x multiple, that's $26M of enterprise value sitting in your churn cohort.

The second symptom is expanding sales cycle length over time. As a company grows, it starts attracting a broader set of prospects. If the GTM motion wasn't designed to handle that variety, your reps spend more time on deals that shouldn't be in the funnel. Each week of sales cycle slip in an enterprise deal costs you real dollars in rep capacity and pipeline velocity.

The third symptom is inconsistent annual contract value (ACV) across segments that should look similar. If your mid-market ACV varies by 40% across reps, you don't have a rep quality problem. You have a positioning problem.

The Operating Model

Three steps for your operating team to use in the first 90 days.

Step 1: Segment your customers by acquisition source and survival rate. Pull cohorts of customers by the channel that originated them: outbound, inbound, partner, self-serve, conference. For each cohort, calculate 12-month retention. This will show you quickly which channels are delivering the right customers and which are generating revenue that leaves before your hold period ends.

Step 2: Map the ideal customer profile (ICP) to the product's actual differentiation. Sit with your product team and list the five things your product does better than alternatives for a specific buyer profile. Then sit with your sales team and list the top five objections they hear in deals. If those two lists don't match, your GTM motion is built on a positioning story the product can't support. That gap is costing you in both conversion and retention.

Step 3: Rebuild the commercial narrative from the outcome back. Enterprise buyers don't buy features. They buy outcomes they can defend internally. Your portfolio company's pitch deck almost certainly leads with product capabilities. Rewrite it from the outcome: "Companies like you achieve X result in Y timeframe." Then work back to the features that deliver that outcome. This is a two-week project that will shorten your sales cycle measurably.

When This Fails

A compliance software company at $18M ARR had been growing at 40% year-over-year for three years before a private equity (PE) acquisition. In the first year post-acquisition, growth slowed to 18% with churn climbing from 8% to 14% annually.

The management team attributed it to market saturation and requested budget for product R&D to build new features. The operating partner pushed back and ran a segmentation analysis.

The finding: the company had gradually shifted its GTM from mid-market compliance directors to enterprise procurement teams. The product was built for the former, not the latter. Enterprise procurement buyers wanted workflow automation that the product didn't support. The sales team was closing those deals with heavy customization promises they couldn't keep.

Before: $18M ARR, 14% annual churn, 18% growth, GTM targeting enterprise buyers with a product built for mid-market.

After: Refocused ICP, repositioned messaging, and a policy of not selling to enterprise accounts without a defined use case the product could fulfill reduced churn to 7% within four quarters. Growth re-accelerated to 31% without new features. The board deferred the R&D request.

Your Next Seven Days

Pull your last 24 months of churn data and segment it by acquisition channel and customer profile. If you can't do that analysis in your current CRM within 48 hours, your data infrastructure is your most urgent GTM problem.

Assess Your Commercial Health to identify where GTM misalignment is suppressing your portfolio company's NRR and growth rate.

Related reading: Why Your Instincts Are Wrong About the Commercial Operating Model and The Operator's Guide to Net Revenue Retention (NRR).

Frequently Asked Questions

What does go-to-market alignment mean for a PE-backed software company?
GTM alignment means your sales motion, marketing positioning, pricing, and customer success approach are all targeting the same buyer with the same value proposition and the same success criteria. Misalignment shows up as high churn in specific segments, long sales cycles, or consistently missed pipeline targets in certain channels.
How does an operating partner diagnose GTM misalignment in the first 90 days?
Start by comparing win rates and churn rates by segment and by acquisition channel. If one channel produces high win rates and low churn while another produces high win rates and high churn, you have a misalignment between what marketing is attracting and what the product can actually deliver.

Find out where your commercial gaps are.

Take the Free Assessment →